Representative Transactions Summary

| |  |  | | |  | 

  1. Exclusive agent for the $80 million private placement of senior unsecured notes of SPS Technologies, Inc. with four insurance companies.
  2. Advisory and placement of $33 million in senior secured notes of CECO Environmental Corp. with three banks, Agented by PNC Bank, NA.
  3. Representation of the shareholders of Commonwealth Scientific, Inc. in its sale to CVC, Inc. which subsequently completed its initial public offering in November of 1999.
  4. Representation of the shareholders of  National Drying Machinery Company in its sale to Apollo Sheet Metal, Inc.
  5. Representation of CECO Environmental Corp. in its acquisition of Kirk & Blum Manufacturing Company.
  6. Founding, incubation, and sourcing of seed capital for RxCentric.com, a business to business internet company which is in the progress of creating the largest electronic marketing channel for pharmaceutical companies to reach physicians.
  7. Advisory services and placement of $73 million in equity to lead the $280 million management buyout of Skellerup, Ltd., a publicly held conglomerate headquartered in Auckland, New Zealand.
  8. $45 million of equity securities issued through four private placement transactions for XOMA Corporation, a publicly held biotechnology company.


  9. Principal investment and placement agent in $25 million private placement of convertible preferred stock for XOMA Corporation, a publicly-held biotechnology company.
  10. Principal investment, advisory services and co-placement agent in a $17 million private placement of common stock for InKine Pharmaceuticals Co. Inc., a publicly-owned drug development company.
  11. Principal investment and placement agent in a $4 million commitment of convertible debentures for CytRx Corp. , a publicly-held pharmaceutical company.
  12. Advisory services and arrangement of a $4 million revolving credit and $3.5 million in 20-year, Industrial Development Revenue Bonds for Nutrition Management Services Company, a publicly held company providing contract food service business for healthcare facilities.

  13. $20 million private placement of convertible debt and equity securities for U.S. Bioscience, Inc. , a publicly held pharmaceutical company which was subsequently acquired  by MedImmune, Inc.
  14. Fairness Opinion provided to Sumitomo Trust & Banking Co., Ltd. with regard to its transfer of certain limited partnership interests.
  15. Provision of financial advisory services and the sourcing of $30 million private placement of equity securities for a privately owned pharmaceutical company.
  16. $50 million private placement of senior secured notes issued by a medium sized privately owned company that participates in the printing industry.
  17. Fairness opinion issued to a publicly-owned French company which increased its investment in a U.S. company from 34% to 97%. This assignment was referred to us by Price Waterhouse & Co.